Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Recruiting
Observational Study
Blood Coagulation Disorders, Inherited
Thrombotic Disorder
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Day – 98
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- The University of Texas Health Science Center, Houston · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: patients with congenital or acquired bleeding or clotting disorders who have provided informed consent and/or assent
Exclusion Criteria: poor venous access
Contacts